Pingxian Liu

451 total citations
25 papers, 357 citations indexed

About

Pingxian Liu is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Pingxian Liu has authored 25 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Organic Chemistry, 9 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Pingxian Liu's work include Bioactive Compounds and Antitumor Agents (5 papers), Cytokine Signaling Pathways and Interactions (4 papers) and Click Chemistry and Applications (3 papers). Pingxian Liu is often cited by papers focused on Bioactive Compounds and Antitumor Agents (5 papers), Cytokine Signaling Pathways and Interactions (4 papers) and Click Chemistry and Applications (3 papers). Pingxian Liu collaborates with scholars based in China and United States. Pingxian Liu's co-authors include Tao Yang, Youfu Luo, Zitai Sang, Tianyu Zhang, Jinhong Chen, Man Guo, Hao Zhang, Zheng Wang, Mingwen Fan and Guobin Yang and has published in prestigious journals such as Journal of Medicinal Chemistry, Chemistry - A European Journal and Molecules.

In The Last Decade

Pingxian Liu

22 papers receiving 354 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pingxian Liu China 11 161 143 48 44 32 25 357
Patrycja Wińska Poland 14 227 1.4× 205 1.4× 32 0.7× 75 1.7× 14 0.4× 45 465
Kristin K. Brown United States 9 461 2.9× 72 0.5× 12 0.3× 33 0.8× 48 1.5× 11 545
Daniel J. Darley United Kingdom 9 320 2.0× 32 0.2× 57 1.2× 22 0.5× 45 1.4× 10 440
Key H. Kim South Korea 9 98 0.6× 149 1.0× 21 0.4× 121 2.8× 27 0.8× 26 319
Bijan Almassian United States 11 121 0.8× 76 0.5× 8 0.2× 120 2.7× 30 0.9× 25 332
Sai Kumar Chakka South Africa 12 139 0.9× 164 1.1× 10 0.2× 28 0.6× 41 1.3× 17 314
Kavita Pal India 14 116 0.7× 89 0.6× 8 0.2× 70 1.6× 19 0.6× 34 429
Dirk A. Bornemeier United States 10 217 1.3× 424 3.0× 49 1.0× 108 2.5× 8 0.3× 14 747
Frank Stappenbeck United States 13 148 0.9× 183 1.3× 8 0.2× 57 1.3× 10 0.3× 25 413
Ze Dong China 13 455 2.8× 161 1.1× 9 0.2× 62 1.4× 38 1.2× 25 642

Countries citing papers authored by Pingxian Liu

Since Specialization
Citations

This map shows the geographic impact of Pingxian Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pingxian Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pingxian Liu more than expected).

Fields of papers citing papers by Pingxian Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pingxian Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pingxian Liu. The network helps show where Pingxian Liu may publish in the future.

Co-authorship network of co-authors of Pingxian Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Pingxian Liu. A scholar is included among the top collaborators of Pingxian Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pingxian Liu. Pingxian Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Jiang, Yunhan, Xiaoqiu Xu, Dongmei Fan, et al.. (2024). Advancing Tumor-Targeted Chemo-Immunotherapy: Development of the CAR-M-derived Exosome-Drug Conjugate. Journal of Medicinal Chemistry. 67(16). 13959–13974. 11 indexed citations
3.
Liu, Pingxian, Huidong Li, Dongmei Fan, et al.. (2024). A novel theranostic strategy for myocardial infarction through neutralization of endogenous SO2 using an endoplasmic reticulum-targeted fluorescent probe. European Journal of Medicinal Chemistry. 277. 116778–116778. 1 indexed citations
4.
Fan, Dongmei, et al.. (2024). Design, synthesis and biological evaluation of novel naphthoquinothiazole derivatives as potent antitumor agents through inhibiting STAT3. Bioorganic Chemistry. 150. 107565–107565. 5 indexed citations
6.
Liu, Pingxian, et al.. (2024). STATs, promising targets for the treatment of autoimmune and inflammatory diseases. European Journal of Medicinal Chemistry. 277. 116783–116783. 3 indexed citations
7.
Zhang, Lidan, Pingxian Liu, Dongmei Fan, et al.. (2024). Exploration of novel isoxazole-fused quinone derivatives as anti-colorectal cancer agents through inhibiting STAT3 and elevating ROS level. European Journal of Medicinal Chemistry. 272. 116448–116448. 4 indexed citations
8.
Liu, Pingxian, et al.. (2024). The U.S. FDA approved cardiovascular drugs from 2011 to 2023: A medicinal chemistry perspective. European Journal of Medicinal Chemistry. 275. 116593–116593. 7 indexed citations
9.
Zhang, Lidan, Yunhan Jiang, Huidong Li, et al.. (2022). Selective and sensitive detection and detoxification of Pd2+ in living cells with a water-soluble fluorescent probe. Analytica Chimica Acta. 1204. 339728–339728. 13 indexed citations
10.
Fan, Dongmei, Pingxian Liu, Yunhan Jiang, et al.. (2022). Discovery and SAR Study of Quinoxaline–Arylfuran Derivatives as a New Class of Antitumor Agents. Pharmaceutics. 14(11). 2420–2420. 4 indexed citations
11.
Yang, Yang, Qi An, Zitai Sang, et al.. (2018). Discovery of novel anti-tuberculosis agents with pyrrolo[1,2-a]quinoxaline-based scaffold. Bioorganic & Medicinal Chemistry Letters. 28(11). 2084–2090. 42 indexed citations
12.
Liu, Pingxian, Yang Yang, Tao Yang, et al.. (2018). Design and synthesis of novel pyrimidine derivatives as potent antitubercular agents. European Journal of Medicinal Chemistry. 163. 169–182. 62 indexed citations
13.
Liu, Pingxian, Yang Yang, Yuan Ju, et al.. (2018). Design, synthesis and biological evaluation of novel pyrrole derivatives as potential ClpP1P2 inhibitor against Mycobacterium tuberculosis. Bioorganic Chemistry. 80. 422–432. 17 indexed citations
14.
Wang, Li, Siping Wei, Xianchao Pan, et al.. (2017). Enhanced Turnover for the P450 119 Peroxygenase‐Catalyzed Asymmetric Epoxidation of Styrenes by Random Mutagenesis. Chemistry - A European Journal. 24(11). 2741–2749. 17 indexed citations
15.
Wang, Li, et al.. (2016). Total Synthesis of Chiral Falcarindiol Analogues Using BINOL-Promoted Alkyne Addition to Aldehydes. Molecules. 21(1). 112–112. 6 indexed citations
16.
Zhang, Chun, Pingxian Liu, Luyi Huang, et al.. (2016). Engineering P450 Peroxygenase to Catalyze Highly Enantioselective Epoxidation of cis‐β‐Methylstyrenes. Chemistry - A European Journal. 22(31). 10969–10975. 20 indexed citations
18.
Yang, Guobin, et al.. (2014). The Effects of Osterix on the Proliferation and Odontoblastic Differentiation of Human Dental Papilla Cells. Journal of Endodontics. 40(11). 1771–1777. 20 indexed citations
19.
Yang, Guobin, Guohua Yuan, Xiaoyan Li, et al.. (2013). BMP-2 Induction of Dlx3 Expression Is Mediated by p38/Smad5 Signaling Pathway in Osteoblastic MC3T3-E1 Cells. Journal of Cellular Physiology. 229(7). 943–954. 28 indexed citations
20.
Liu, Pingxian. (2008). Preparation of Alumina and Silica White from Oil Shale Residue. Mining and Metallurgical Engineering. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026